Growing cybersecurity leadership Nova Leah is a world leader in cybersecurity risk management for medical device manufacturers and healthcare providers, presenting a strong value proposition for healthcare organizations seeking robust third party risk management and continuous monitoring solutions.

New SelectEvaluate launch The October 2023 rollout of SelectEvaluate expands Nova Leah’s platform capabilities into third party risk management and continuous monitoring, creating cross-sell opportunities for existing customers and a compelling entry point for health systems prioritizing supply chain security.

Industry credibility Past funding and awards, including seed investment from Northwell Health and multiple startup awards, bolster credibility with enterprise buyers and health systems that require proven vendors with healthcare-specific cybersecurity expertise.

Small team, strategic focus With a lean team and a global reach, Nova Leah can partner with larger medical device manufacturers and health networks for rapid piloting and scalable deployments, while leveraging channel partners to extend market access.

Growth through partnerships Given their focus on medical device cybersecurity across the healthcare supply chain and the recent product expansion, targeted collaboration with large health systems, device manufacturers, and integration partners could accelerate adoption and drive expand/upsell scenarios.